CONCORD, Mass., Nov. 3 /PRNewswire-USNewswire/ -- The Melanoma Foundation of New England invites melanoma patients, survivors, families, and friends to its fall symposium: "Updates in Melanoma Treatment" presented by F. Stephen Hodi, MD, Director of the Melanoma Program at Dana Farber Cancer Institute. A portion of the symposium also presented by Dr. Hodi is "Immunotherapy: A Panel Presentation," which includes a panel of melanoma experts who will discuss the use of interferon and interleukin-2 in treating melanoma. Presenters will include: Donald Lawrence, MD, Clinical Director of the Center for Melanoma at Massachusetts General Hospital (MGH) Cancer Center; Krista Rubin, NP, Nurse Practitioner at the MGH Center for Melanoma, and Frank McCaffrey, LICSW-OSW-C, Oncology Social Worker in the Biologics Program at Beth Israel Deaconess Medical Center, and melanoma survivors.
The symposium is on Monday, November 17, 2008, 6:30 - 9:00 pm, at Dana Farber, Jimmy Fund Auditorium, 35 Binney Street, Boston, MA. There is no charge for the program and parking is free in the Smith Building at 1 Jimmy Fund Way. Please RSVP by calling 978-371-5613 or emailing Cristina Finn at firstname.lastname@example.org
The Melanoma Foundation of New England is a non-profit organization dedicated to educating the public about the importance of early detection and prevention, and helping patients and their caregivers cope with melanoma. Skin cancer is the number one diagnosed cancer in the United States. Melanoma is the most preventable cancer. The Foundation was founded in 1999 and is a 501(c) (3) non-profit organization that provides educational programs, support groups, and advocacy for melanoma patients. Learn more about the Foundation at: http://www.mfne.org.
|SOURCE Melanoma Foundation of New England|
Copyright©2008 PR Newswire.
All rights reserved